Omix Technologies

Omix Technologies is a private life science tools and omics platform company focused on ultra high-throughput quantitative proteomics and metabolomics. The company uses mass spectrometry-based workflows and a 96-well platform to generate large-scale molecular datasets for applications in blood products, regenerative medicine, personalized medicine, and omics-guided drug screening. Its capabilities are positioned to support drug discovery, drug repurposing, transfusion medicine, extracellular matrix characterization, and next-generation cell therapy development. Rather than operating as a traditional therapeutic developer with a disclosed clinical pipeline, Omix appears to commercialize analytical technologies and research services for biotech and biomedical applications.